Video
Bausch + Lomb: clinical trial, pipeline updates for 2021
Author(s):
Yolande Barnard, vice president and general manager of U.S. Pharmaceuticals at Bausch + Lomb, shares an update on the company's latest treatment for patients with DED associated with MGD as well as an investigational drug for the treatment of macular edema associated with uveitis.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
